$LSB News
Last published 1y ago
- 1y agoLSBLakeShore Biopharma Announces Transition to OTC Market Following Nasdaq DelistingPR NewswireLakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering,...
- 1y agoLSBLakeShore Biopharma Announces Receipt of Delisting Determination Letter from NasdaqPR NewswireLakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering,...
- 1y agoLSBLakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special CommitteePR NewswireLakeShore Biopharma Co., Ltd (Nasdaq: LSB, "LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering,...
- 1y agoLSBLakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special CommitteePR NewswireLakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering,...
- 1y agoLSBLakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the CompanyPR NewswireLakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering,...
- 1y agoLSBLakeShore Biopharma Announces Fiscal Year 2025 Financial ResultsPR NewswireLakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering,...
- 1y agoLSBLakeShore Biopharma Announces US$15 Million Private Placement FinancingPR NewswireLakeShore Biopharma Co., Ltd (Nasdaq: LSB) (the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing,...
- 1y agoLSBLakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell)PR NewswireOn April 18, 2025, LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company") successfully held the 2025 CSO ("Contract...
- 1y agoLSBLakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year GuidancePR NewswireLakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...
- 1y agoLSBLakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in ChinaGlobeNewswireBEIJING, Dec. 12, 2024 (GLOBE NEWSWIRE) -- LakeShore Biopharma Co., Ltd. (NASDAQ:LSB) ("LakeShore Biopharma" or the "Company"), a leading global biopharmaceutical company focused on the innovation and production of
- 2y agoLSBYSLakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of PakistanGlobeNewswireGAITHERSBURG, Md., Nov. 07, 2024 (GLOBE NEWSWIRE) -- LakeShore Biopharma Co., Ltd (NASDAQ:LSB) ("LakeShore Biopharma" or the "Company"), a global leader in the discovery, development, manufacturing, and delivery of
- 2y agoLSBLakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price RequirementPR NewswireLakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering,...
- 2y agoLSBLakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies VaccinePR NewswireLakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering,...
- 2y agoLSBLakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial GuidancePR NewswireLakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering,...
- 2y agoLSBLakeShore Biopharma Announces Results of Extraordinary General Meeting on Share ConsolidationPR NewswireLakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering,...
- 2y agoLSBLakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024PR NewswireLakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering,...
- 2y agoLSBLakeShore Biopharma Announces Leadership TransitionsPR NewswireLakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering,...
- 2y agoLSBLakeShore Biopharma Announces Financial Results for Fiscal Year 2024PR NewswireLakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering,...
- 2y agoLSBLakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' RequisitionPR NewswireLakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering,...